OLMA OLEMA PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2023 - Amendment to Clinical Collaboration Agreement Olema Pharmaceuticals, Inc. entered into an Amendment to increase the size of its clinical study with Novartis.Get access to all SEC 8-K filings of the OLEMA PHARMACEUTICALS INC